Increased plasma 7β-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 967-971

  Ziedén, Bo ^b   Kaminskas, Arvydas ^a   Kristenson, Margareta ^b   Kucinskienê, Zita ^a   Vessby, Bengt ^c   Olsson, Anders G ^b   Diczfalusy, Ulf ^d  

^a VILNIUS UNIVERSITY   (Lithuania)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cross sectional study; Fatty acids; LDL oxidation; Oxysterols; Vitamins

Indexed keywords

7BETA HYDROXYCHOLESTEROL; ALPHA TOCOPHEROL; FATTY ACID; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; AUTOOXIDATION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; LITHUANIA; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SWEDEN;

EID: 0032918516     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.967     Document Type: Article

References (25)

1. Uemura K, Zbynek P. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q. 1988;41: 155-178.
2. Bobak M, Marmot M. East-West mortality divide and its potential explanations: proposed research agenda. BMJ. 1996;312:421-425.
3. Feachem R. Health decline in Eastern Europe. Nature. 1994;367: 313-314.
4. Kristenson M, Ziedén B, Kucinskienê Z, et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ. 1997;314: 629-633.
5. Ziouzenkova O, Winklhofer-Roob B, Puhl H, Roob J, Esterbauer H. Lack of correlation between the alfa-tocopherol content of plasma and LDL, but high correlation for gamma-tocopherol and carotenoids. J Lipid Res. 1996;37:1936-1946.
6. Patel R, Diczfalusy U, Dzeletovic S, Wilson M, Darley-Usmar V. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin and copper. J Lipid Res. 1996;37:2361-2371.
7. Salonen J, Nyyssönen K, Salonen R, Porkkala E, Tuomainen TP, Diczfalusy U, Björkhem I. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation. 1997;95:840-845.
8. Williamson D, Kahn H, Worthman C, Burnette J, Russel C. Precision of recumbent anthrometry. Am J Hum Biol. 1993;15:159-167.
9. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
10. Kleinveld H, Hak-Lemmers H, Stalenhoef A, Demacker P. Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem. 1992;38:2066-2072.
11. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
12. Folch J, Lees M, Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226: 497-509.
13. Öhrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J Intern Med. 1993;234:53-60.
14. Thurnham D, Davies J, Crump B, Situnayake R. The use of different lipids to express serum tocopherol:lipid ratios for the measurement of vitamin E status. Ann Clin Biochem. 1986;23:514-520.
15. Öhrwall M, Tengblad S, Ekstrand B, Siegbahn A, Vessby B. Malondialdehyde concentration in plasma is inversely correlated to the proportion of linoleic acid in serum lipids. Atherosclerosis. 1994;108:103-110.
16. Dzeletovic S, Breuer O, Lund E, Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem. 1995;225:73-80.
17. Kudo K, Emmons G, Casserly E, et al. Inhibitors of sterol synthesis. Chromatography of acetate derivatives of oxygenated sterols. J Lipid Res. 1989;30:1097-1111.
18. Karten B, Beisiegel U, Gercken G, Kontush A. Mechanisms of lipid peroxidation in human blood plasma: a kinetic approach. Chem Phys Lipids. 1997;88:83-96.
19. Brown A. Acute effects of smoking cessation on antioxidant status. J Nutr Biochem. 1996;7:29-39.
20. Sinha R, Patterson B, Mangels A, et al. Determinants of plasma vitamin E in healthy males. Cancer Epidemiol Biomarkers Prev. 1993;2: 473-479.
21. Stampfer M, Hennekens C, Mansson J, Colditz G, Rosner B, Willett W. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
22. Rimm E, Stampfer M, Ascherio A, Giovannucci E, Colditz G, Willett W. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
23. Öhrvall M, Sundlöf G, Vessby B. Gamma, but not alpha tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med. 1996;239:111-117.
24. Cooney R, Franke A, Harwood P, Hatch-Pigott V, Custer L, Mordan L. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sci U S A. 1993;90:1771-1775.
25. Christen S, Woodall A, Shigenaga M, Southwell-Keely P, Duncan M, Ames B. γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: physiological implications. Proc Natl Acad Sci U S A. 1997;94:3217-3222.